Short‐term costs of preeclampsia to the United States health care system

[1]  A. Bartley,et al.  The impact of postpartum hemorrhage on hospital length of stay and inpatient mortality: a National Inpatient Sample–based analysis , 2017, American journal of obstetrics and gynecology.

[2]  W. Callaghan,et al.  Pregnancy-Related Mortality in the United States, 2011-2013. , 2017, Obstetrics and gynecology.

[3]  J. Meeker,et al.  Repeated measures of inflammation and oxidative stress biomarkers in preeclamptic and normotensive pregnancies , 2017, American journal of obstetrics and gynecology.

[4]  T. Henriksen,et al.  In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies. , 2016, American journal of obstetrics and gynecology.

[5]  B. Sibai,et al.  Biomarkers for Prediction, Risk Stratification, and Ruling Out Preeclampsia: What Are the Appropriate Goals and Objectives? , 2016, American Journal of Perinatology.

[6]  J. Cross,et al.  Placental origins of adverse pregnancy outcomes: potential molecular targets: an Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human Development. , 2016, American journal of obstetrics and gynecology.

[7]  G. Rice,et al.  Role of Extracellular Vesicles and microRNAs on Dysfunctional Angiogenesis during Preeclamptic Pregnancies , 2016, Front. Physiol..

[8]  S. Karumanchi,et al.  Preeclampsia and Pregnancy-Related Hypertensive Disorders. , 2016, Hypertension.

[9]  Douglas G Altman,et al.  Inverse probability weighting , 2016, British Medical Journal.

[10]  M. Kramer,et al.  The association between maternal antioxidant levels in midpregnancy and preeclampsia. , 2015, American journal of obstetrics and gynecology.

[11]  R. Ehrenkranz,et al.  The Rising Burden of Preeclampsia in the United States Impacts Both Maternal and Child Health , 2015, American Journal of Perinatology.

[12]  C. Redman,et al.  Preeclampsia, biomarkers, syncytiotrophoblast stress, and placental capacity. , 2015, American journal of obstetrics and gynecology.

[13]  A. Moffett,et al.  The role of shed placental DNA in the systemic inflammatory syndrome of preeclampsia. , 2015, American journal of obstetrics and gynecology.

[14]  W. Jaber,et al.  Outcomes After Acute Ischemic Stroke in the United States: Does Residential ZIP Code Matter? , 2015, Journal of the American Heart Association.

[15]  H. Cloft,et al.  Hospitalization Costs for Acute Myocardial Infarction Patients Treated With Percutaneous Coronary Intervention in the United States Are Substantially Higher Than Medicare Payments , 2015, Clinical cardiology.

[16]  C. Ananth,et al.  Preeclampsia Rates in the United States, 1980 to 2010: Age-Period-Cohort Analysis , 2014 .

[17]  Joshua T. Cohen,et al.  Updating cost-effectiveness--the curious resilience of the $50,000-per-QALY threshold. , 2014, The New England journal of medicine.

[18]  P. Kaleebu,et al.  Pregnancy, parturition and preeclampsia in women of African ancestry , 2014, American journal of obstetrics and gynecology.

[19]  C. Murray,et al.  The Global Burden of Ischemic Heart Disease in 1990 and 2010: The Global Burden of Disease 2010 Study , 2014, Circulation.

[20]  Christine H Morton,et al.  California Pregnancy-Associated Mortality Review: Mixed Methods Approach for Improved Case Identification, Cause of Death Analyses and Translation of Findings , 2014, Maternal and Child Health Journal.

[21]  C. Ananth,et al.  Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysis , 2013, BMJ.

[22]  C. Berg,et al.  Incidence, risk factors, and temporal trends in severe postpartum hemorrhage. , 2013, American journal of obstetrics and gynecology.

[23]  A. Jeyabalan,et al.  Epidemiology of preeclampsia: impact of obesity. , 2013, Nutrition reviews.

[24]  Foreman,et al.  The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. , 2013, JAMA.

[25]  C. Patterson,et al.  Impaired lung function and health status in adult survivors of bronchopulmonary dysplasia , 2013, European Respiratory Journal.

[26]  Christopher J. L. Murray,et al.  Temporal Trends in Ischemic Heart Disease Mortality in 21 World Regions, 1980 to 2010: The Global Burden of Disease 2010 Study , 2013, Circulation.

[27]  M. Pearce,et al.  Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis , 2013, European Journal of Epidemiology.

[28]  Jeffrey M. Wooldridge,et al.  What Are We Weighting For? , 2013, The Journal of Human Resources.

[29]  Richard Williams,et al.  Using the Margins Command to Estimate and Interpret Adjusted Predictions and Marginal Effects , 2012 .

[30]  Xue Zhou,et al.  A novel bridge between oxidative stress and immunity: the interaction between hydrogen peroxide and human leukocyte antigen G in placental trophoblasts during preeclampsia. , 2012, American journal of obstetrics and gynecology.

[31]  K. Joseph,et al.  Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. , 2011, Best practice & research. Clinical obstetrics & gynaecology.

[32]  R. L. Moss,et al.  Necrotizing enterocolitis: an update. , 2011, Seminars in fetal & neonatal medicine.

[33]  M. Gokhale,et al.  Population-based trends in pregnancy hypertension and pre-eclampsia: an international comparative study , 2011, BMJ Open.

[34]  C. Berg,et al.  Pregnancy-Related Mortality in the United States, 1998 to 2005 , 2010, Obstetrics and gynecology.

[35]  B. Poindexter,et al.  Neonatal Outcomes of Extremely Preterm Infants From the NICHD Neonatal Research Network , 2010, Pediatrics.

[36]  Shiliang Liu,et al.  Temporal trends and regional variations in severe maternal morbidity in Canada, 2003 to 2007. , 2010, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[37]  L. Doyle,et al.  Adult Outcome of Extremely Preterm Infants , 2010, Pediatrics.

[38]  M. Olovsson,et al.  Evidence of increased oxidative stress and a change in the plasminogen activator inhibitor (PAI)-1 to PAI-2 ratio in early-onset but not late-onset preeclampsia. , 2009, American journal of obstetrics and gynecology.

[39]  J. Olsen,et al.  Health of children born to mothers who had preeclampsia: a population-based cohort study. , 2009, American journal of obstetrics and gynecology.

[40]  Jürgen Rehm,et al.  Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders , 2009, The Lancet.

[41]  T. Dall,et al.  Cost of gestational diabetes mellitus in the United States in 2007. , 2009, Population health management.

[42]  W. Callaghan,et al.  Hypertensive Disorders and Severe Obstetric Morbidity in the United States , 2009, Obstetrics and gynecology.

[43]  B. Sibai,et al.  Hypertensive Pregnancy Disorders and Subsequent Cardiovascular Morbidity and Type 2 Diabetes Mellitus in the Mother , 2009, Hypertension.

[44]  J. Eriksson,et al.  Pre-Eclampsia Is Associated With Increased Risk of Stroke in the Adult Offspring: The Helsinki Birth Cohort Study , 2009, Stroke.

[45]  Kari Ferver,et al.  The use of claims data in healthcare research. , 2009 .

[46]  J. Zupancic,et al.  Cost-effectiveness of Early Treatment for Retinopathy of Prematurity , 2009, Pediatrics.

[47]  R. Romero,et al.  Evidence of maternal platelet activation, excessive thrombin generation, and high amniotic fluid tissue factor immunoreactivity and functional activity in patients with fetal death , 2009, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[48]  M. Knight,et al.  Eclampsia in the United Kingdom 2005. , 2008, BJOG : an international journal of obstetrics and gynaecology.

[49]  T. Leivestad,et al.  Preeclampsia and the risk of end-stage renal disease. , 2008, The New England journal of medicine.

[50]  N. Marlow,et al.  Respiratory health in pre-school and school age children following extremely preterm birth , 2008, Archives of Disease in Childhood.

[51]  Anne B Wallis,et al.  Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987-2004. , 2008, American journal of hypertension.

[52]  M. Weinstein.  How much are Americans willing to pay for a quality-adjusted life year? , 2008, Medical care.

[53]  M. Roberts,et al.  What Does the Value of Modern Medicine Say About the $50,000 per Quality-Adjusted Life-Year Decision Rule? , 2008, Medical care.

[54]  D. Henderson-smart,et al.  Using hospital discharge data for determining neonatal morbidity and mortality: a validation study , 2007, BMC Health Services Research.

[55]  A. Hingorani,et al.  Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis , 2007, BMJ : British Medical Journal.

[56]  B. Sibai.  Biomarker for hypertension-preeclampsia: are we close yet? , 2007, American journal of obstetrics and gynecology.

[57]  Volker Amelung,et al.  The value of health care – a matter of discussion in Germany , 2007, BMC Health Services Research.

[58]  C. Weinberg,et al.  Long-term fatty fish consumption and renal cell carcinoma incidence in women. , 2006, JAMA.

[59]  C. Hollenbeak,et al.  Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital* , 2006, Critical care medicine.

[60]  T. Libermann,et al.  Soluble endoglin contributes to the pathogenesis of preeclampsia , 2006, Nature Medicine.

[61]  A Metin Gülmezoglu,et al.  WHO analysis of causes of maternal death: a systematic review , 2006, The Lancet.

[62]  M. Schull,et al.  Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study , 2005, The Lancet.

[63]  S. Koh,et al.  Coagulation and Fibrinolysis in Preeclampsia and Neonates , 2005, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[64]  A. Cameron,et al.  Microeconometrics: Methods and Applications , 2005 .

[65]  B. Vohr,et al.  Neurodevelopmental and Growth Outcomes of Extremely Low Birth Weight Infants After Necrotizing Enterocolitis , 2005, Pediatrics.

[66]  E. Palmer,et al.  15-year outcomes following threshold retinopathy of prematurity: final results from the multicenter trial of cryotherapy for retinopathy of prematurity. , 2005, Archives of ophthalmology.

[67]  D. Cabrol,et al.  Maternal and perinatal outcomes during expectant management of 239 severe preeclamptic women between 24 and 33 weeks' gestation. , 2004, American journal of obstetrics and gynecology.

[68]  S. Kilpatrick,et al.  International Classification of Diseases-9th revision coding for preeclampsia: how accurate is it? , 2004, American journal of obstetrics and gynecology.

[69]  K. Lim,et al.  Circulating angiogenic factors and the risk of preeclampsia. , 2004, The New England journal of medicine.

[70]  T. Libermann,et al.  Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. , 2003, The Journal of clinical investigation.

[71]  T. Libermann,et al.  Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia , 2003 .

[72]  S. Bachrach,et al.  HRQL and severity of brain ultrasound findings in a cohort of adolescents who were born preterm. , 2002, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[73]  L. Schall,et al.  Long-term follow-up of patients with necrotizing enterocolitis. , 2002, Journal of pediatric surgery.

[74]  A. Ivinson.  Macroeconomics and Health: Investing in Health for Economic Development , 2002, Nature Medicine.

[75]  R. Romero,et al.  Phenotypic and metabolic characteristics of monocytes and granulocytes in preeclampsia. , 2001, American journal of obstetrics and gynecology.

[76]  D. Elbourne,et al.  Randomised controlled trial of prophylactic etamsylate: follow up at 2 years of age , 2001, Archives of disease in childhood. Fetal and neonatal edition.

[77]  C. Berg,et al.  Pregnancy‐Related Mortality From Preeclampsia and Eclampsia , 2001, Obstetrics and gynecology.

[78]  B. B. Mettelman,et al.  Impact of family structure and stability on academic outcome in preterm children at 10 years of age. , 2001, The Journal of pediatrics.

[79]  James J. Walker,et al.  Pre-eclampsia , 2000, The Lancet.

[80]  E L Korn,et al.  Predictive Margins with Survey Data , 1999, Biometrics.

[81]  I. Sargent,et al.  Preeclampsia: an excessive maternal inflammatory response to pregnancy. , 1999, American journal of obstetrics and gynecology.

[82]  J. Morris,et al.  Serum from preeclamptic women induces vascular cell adhesion molecule-1 expression on human endothelial cells in vitro: a possible role of increased circulating levels of free fatty acids. , 1998, American journal of obstetrics and gynecology.

[83]  I. Sargent,et al.  Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. , 1998, American journal of obstetrics and gynecology.

[84]  C. Leonard,et al.  Outcome of extremely low birth weight infants (500 to 999 grams) over a 12-year period. , 1997, Pediatrics.

[85]  C. Ananth,et al.  Preeclampsia and Preterm Birth Subtypes in Nova Scotia, 1986 to 1992 , 1997, American journal of perinatology.

[86]  I. Sargent,et al.  Endothelial cell proliferation is suppressed by plasma but not serum from women with preeclampsia. , 1996, American journal of obstetrics and gynecology.

[87]  C. Redman,et al.  Eclampsia in the United Kingdom , 1994, BMJ.

[88]  T. Musci,et al.  Preeclampsia: an endothelial cell disorder. , 1989, American journal of obstetrics and gynecology.

[89]  N. Duan.  Smearing Estimate: A Nonparametric Retransformation Method , 1983 .

[90]  P. Noone,et al.  NECROTISING ENTEROCOLITIS , 1977, The Lancet.

[91]  W. Fraser,et al.  Preeclampsia and Long-term Risk of Maternal Retinal Disorders. , 2017, Obstetrics and gynecology.

[92]  Richard J. K. Taylor,et al.  Office of Statewide Health Planning and Development , 2015 .

[93]  N. Waitzman,et al.  Surgical Volume, Hospital Quality, and Hospitalization Cost in Congenital Heart Surgery in the United States , 2014, Pediatric Cardiology.

[94]  Sw Terwilliger.  15-Year outcomes following threshold retinopathy of prematurity: Final results from the Multicenter Trial of Cryotherapy for Retinopathy of Prematurity , 2006 .

[95]  M. Moseley,et al.  Long-term ophthalmic outcome of low birth weight children with and without retinopathy of prematurity. , 2002, Pediatrics.

[96]  S. Finkler.  The distinction between cost and charges. , 1982, Annals of internal medicine.